Shenzhen Salubris Pharmaceuticals Co., Ltd.
SZSE:002294.SZ
29.64 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 3,321.786 | 3,482.011 | 3,058.392 | 2,738.562 | 4,470.466 | 4,651.876 | 4,153.777 | 3,833.49 | 3,477.693 | 2,882.645 | 2,327.484 | 1,828.882 | 1,474.885 | 1,297.767 | 849.598 | 527.17 | 349.435 | 203.144 |
| Kosten van de omzet
| 1,127.141 | 993.612 | 793.279 | 847.697 | 964.366 | 943.673 | 785.056 | 949.879 | 912.288 | 764.854 | 564.619 | 465.422 | 559.862 | 555.592 | 376.41 | 259.36 | 185.872 | 107.099 |
| Brutowinst
| 2,194.645 | 2,488.399 | 2,265.113 | 1,890.865 | 3,506.1 | 3,708.203 | 3,368.721 | 2,883.611 | 2,565.404 | 2,117.791 | 1,762.864 | 1,363.46 | 915.022 | 742.175 | 473.187 | 267.809 | 163.563 | 96.045 |
| Brutowinstmarge
| 0.661 | 0.715 | 0.741 | 0.69 | 0.784 | 0.797 | 0.811 | 0.752 | 0.738 | 0.735 | 0.757 | 0.746 | 0.62 | 0.572 | 0.557 | 0.508 | 0.468 | 0.473 |
| Onderzoek- en ontwikkelingskosten
| 376.371 | 533.75 | 357.368 | 371.195 | 763.497 | 407.477 | 327.054 | 224.273 | 175.765 | 121.18 | 127.608 | 112.328 | 77 | 66.596 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 102.809 | 62.37 | 60.738 | 48.138 | 51.114 | 52.467 | 53.098 | 43.567 | 44.656 | 27.048 | 22.527 | 32.832 | 16.411 | 12.559 | 53.482 | 29.887 | 21.16 | 13.427 |
| Verkoop- en marketingkosten
| 1,015.589 | 1,094.427 | 1,035.866 | 899.198 | 1,576.269 | 1,345.644 | 1,155.732 | 852.075 | 775.144 | 713.013 | 594.467 | 453.183 | 332.303 | 256.385 | 168.877 | 111.4 | 65.161 | 44.088 |
| Verkoop-, algemene en administratieve kosten
| 1,267.829 | 1,156.797 | 1,096.604 | 947.336 | 1,627.383 | 1,398.111 | 1,208.83 | 895.641 | 819.8 | 740.061 | 616.994 | 486.014 | 348.715 | 268.945 | 222.359 | 141.287 | 86.321 | 57.515 |
| Overige kosten
| 1.589 | 165.366 | 233.995 | 203.955 | 229.045 | -13.716 | 0.7 | 22.048 | 13.289 | 10.907 | 15.065 | 20.807 | 8.387 | 2.777 | 4.536 | 3.105 | 0.616 | -0.664 |
| Bedrijfskosten
| 1,642.61 | 1,855.913 | 1,687.968 | 1,522.486 | 2,619.925 | 2,014.885 | 1,710.71 | 1,279.38 | 1,106.622 | 943.704 | 809.209 | 647.532 | 461.594 | 344.709 | 223.013 | 141.709 | 86.586 | 57.685 |
| Bedrijfsresultaat
| 552.034 | 727.436 | 586.195 | 348.723 | 846.081 | 1,719.962 | 1,714.623 | 1,630.848 | 1,478.478 | 1,207.186 | 967.764 | 729.794 | 466.774 | 412.72 | 245.703 | 123.527 | 76.151 | 37.331 |
| Bedrijfsresultaat ratio
| 0.166 | 0.209 | 0.192 | 0.127 | 0.189 | 0.37 | 0.413 | 0.425 | 0.425 | 0.419 | 0.416 | 0.399 | 0.316 | 0.318 | 0.289 | 0.234 | 0.218 | 0.184 |
| Totaal overige inkomsten en kosten netto
| 105.184 | -13.711 | 13.647 | -291.981 | 5.265 | 12.927 | 57.312 | 46.244 | 32.705 | 43.276 | 22.779 | 34.361 | 21.132 | 18.022 | -0.822 | 0.532 | -0.387 | -1.693 |
| Inkomen voor belasting
| 657.218 | 713.725 | 599.842 | 56.743 | 851.346 | 1,706.246 | 1,715.323 | 1,650.475 | 1,491.488 | 1,217.363 | 976.434 | 750.288 | 474.56 | 415.488 | 249.352 | 126.632 | 76.59 | 36.667 |
| Inkomen voor belasting ratio
| 0.198 | 0.205 | 0.196 | 0.021 | 0.19 | 0.367 | 0.413 | 0.431 | 0.429 | 0.422 | 0.42 | 0.41 | 0.322 | 0.32 | 0.293 | 0.24 | 0.219 | 0.18 |
| Belastingkosten
| 60.932 | 79.507 | 71.52 | 6.608 | 169.505 | 251.665 | 278.442 | 260.436 | 221.814 | 173.979 | 143.174 | 114.736 | 69.112 | 59.978 | 33.673 | 9.69 | 3.452 | 2.428 |
| Nettowinst
| 580.066 | 637.091 | 533.727 | 60.865 | 715.201 | 1,458.223 | 1,451.887 | 1,396.414 | 1,265.92 | 1,042.297 | 830.417 | 635.168 | 405.249 | 355.314 | 215.747 | 116.942 | 73.138 | 34.239 |
| Nettowinstmarge
| 0.175 | 0.183 | 0.175 | 0.022 | 0.16 | 0.313 | 0.35 | 0.364 | 0.364 | 0.362 | 0.357 | 0.347 | 0.275 | 0.274 | 0.254 | 0.222 | 0.209 | 0.169 |
| WPA (Winst Per Aandeel)
| 0.53 | 0.58 | 0.5 | 0.059 | 0.69 | 1.39 | 1.39 | 1.33 | 1.21 | 1 | 0.79 | 0.61 | 0.39 | 0.34 | 0.25 | 0.15 | 0.093 | 0.052 |
| Verwaterde WPA
| 0.53 | 0.58 | 0.5 | 0.059 | 0.69 | 1.39 | 1.39 | 1.33 | 1.21 | 1 | 0.79 | 0.61 | 0.39 | 0.34 | 0.25 | 0.15 | 0.093 | 0.052 |
| EBITDA
| 927.472 | 1,093.466 | 1,070.819 | 594.749 | 1,107.031 | 1,882.403 | 1,828.37 | 1,769.367 | 1,541.69 | 1,242.369 | 1,018.969 | 765.879 | 492.117 | 443.336 | 267.611 | 137.588 | 84.217 | 42.55 |
| EBITDA ratio
| 0.279 | 0.314 | 0.35 | 0.217 | 0.248 | 0.405 | 0.44 | 0.462 | 0.443 | 0.431 | 0.438 | 0.419 | 0.334 | 0.342 | 0.315 | 0.261 | 0.241 | 0.209 |